SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Jumper who wrote (2561)2/26/1998 5:08:00 PM
From: F. Jay Abella, III  Respond to of 7041
 
Linda:

$12 is the figure that would represent a 25% decline in ZONA from the $16 level ZONA was on Jan 8, 1998 (my benchmark).

I heard that the article already appeared somewhere else. If so, I will quote a CEO who told me once "its news to people who haven't heard it already." Hmmm.

FJA

PS - Bart Chapman, MD at Josephthal says in the Feb 15 Genetic Engineering News that he thinks ZONA is 30 sometime in 1998. His benchmark is $18.125. Caution; he also liked SNUS at 34.625 (now $25), but AQLA has had a nice run to $7.